SubQ Society
A permanent record of what we could see on 2026-09-20. Share it, cite it, or download it.
Educational peptide dosing calculator site with no sales or contact details
SubQ Society provides an interactive peptide calculator for educational dosing estimates. The site does not sell products, operate a storefront, or publish business entity details, contact information, or laboratory test certificates.
Confidence: medium · 1 pages read · 0 documents opened · 2026-09-20 13:47 UTC
We could read a fair amount, but parts of the picture stayed closed.
Weak. Below the median of the 125 research suppliers we have scored (6.0).
- Strong8.0 – 10
- Good6.5 – 7.9
- Mixed5.0 – 6.4
- Weak0 – 4.9
- 1The site functions as an educational peptide dosing calculator and does not list any products for sale.
- 2No business entity, physical address, or direct contact details are provided on the page.
- 3No laboratory analysis or product purity documentation is available on the site.
Third-party test reports: are they recent, lot-linked, and do they use methods that can actually prove identity and amount?
- Published test reportsFlagged
We found no certificates anywhere we could read on the site — no files, and no scans on the pages we opened. For a research-use seller this is the single most important thing to publish.
- Reports tied to a lotNot visible
No documents to trace back to a batch.
- What the reports sayFlagged
No third-party testing reports or certificates of analysis are provided.
- Analytical methodNot visible
No analytical method (HPLC, LC-MS, mass spec) is named anywhere we could read. Purity claimed without a method is a number without a source.
- Named third-party labNot visible
No outside laboratory is named. In-house numbers are not independent evidence.
- Document recencyNot visible
The documents carry no date we could read.
Third-party ratings and public threads, read directly at the moment of this check. They are easy to buy and easy to brigade, so they are weighted low and can never overturn a lab-evidence flag. Every source below is also logged in the evidence trail.
Trustpilot did not answer, so we treat their reputation there as not visible.
Read 2026-09-20 13:47 UTC
No Google rating we could read from here. Google blocks automated reads, so open the link and judge it yourself.
Read 2026-09-20 13:47 UTC
No public community discussion we could read. Silence is not a verdict either way.
Read 2026-09-20 13:47 UTC
Every claim in this report traces to one of the items above. Expand a row to see the material it is based on.
The score is a weighted mean over the pillars we could actually read — 70% of the model on this run. Anything we could not see is left out of the maths rather than counted against the seller.
Model weight 34% · pillar score 0.0/10 · 0 ok, 2 flagged, 4 unseen
Model weight 24% · pillar score 4.0/10 · 2 ok, 3 flagged, 2 unseen
Model weight 18% · nothing readable · 0 ok, 0 flagged, 3 unseen
Model weight 12% · pillar score 0.0/10 · 0 ok, 1 flagged, 2 unseen
Model weight 12% · nothing readable · 0 ok, 0 flagged, 3 unseen
Reputation is deliberately the lightest pillar. Even a perfect rating cannot lift a report over a lab-evidence flag.
Paste the citation straight into a paper or a reference manager. Both files carry the run identifier and the timestamp of this report.
MyDosage. MyDosage supply check: SubQ Society (1.4/10). 2026-09-20. https://mydosage.com/c/13676adc-6cd2-40da-95f0-7a7ab758b3c8
The pack is one PDF: the verdict page plus an appendix of every cited page, document and social-proof source with the text we read. The data exports carry the same thing in machine form — inputs, every source with its timestamp and confidence weight, and the full scoring breakdown.
Whatever this report said, there are three ways to get what you need.
- 1Doctor + approved medicineA prescription and a pharmacy-dispensed product with a regulator's label.
- 2Clinic + licensed compounding pharmacyA prescriber and a pharmacy we checked against its licence register.
- 3Research-use-only supplierNo medical oversight. Only worth it when nothing approved exists yet.
Prices, oversight and typical wait are compared side by side for United States.